Conmed (CNMD) Tops Q3 EPS by 65c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $45.42 -1.54%
EPS Growth %: -7.4%
Financial Fact:
Interest expense: 3.86M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -7.4%
Financial Fact:
Interest expense: 3.86M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.88, $0.65 better than the analyst estimate of $0.23. Revenue for the quarter came in at $237.8 million versus the consensus estimate of $205.92 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
